During the Covid-19 pandemic, scientists worldwide formed the Covid Moonshot to create an open-source antiviral. Despite challenges, including displaced Ukrainian team members, their patent-free treatment is nearing human trials. Led by Annette von Delft of the University of Oxford, this effort aims to provide accessible treatments for Covid and other diseases. While commercial antivirals like Pfizer’s Paxlovid have seen diminished demand, the need for affordable, effective treatments persists amid ongoing virus mutations and case surges





